1,1,1-TRIPHENYL-2,5,8,11-TETRAOXATRIDECAN-13-OL, 95%, 250mg

N-Phenylpyridin-2-amine>97.0%(GC)(T)1g

2-Methoxy-4-nitro-1-(trifluoromethyl)benzene, 95.0%, 1g

7-bromo-2,3-dihydro-1,3-benzothiazole-2-thione, 95%, 10g

2,2'-BIPYRIDINE-5,5'-DIOL, 98%, 50mg

4-methoxy-2,3-dimethylpyridin-1-ium-1-olate, 5g

2,6-Dichloropyrimidine-4-carbonitrile, 95.0%, 10g

2-Amino-5-bromo-3-chloropyrazine, 95.0%, 5g

5-Amino-2-(methylthio)pyrimidine-4-carboxylic acid, 95.0%, 5g

3-(Aminomethyl)-1-tert-butoxycarbonylpiperidine>98.0%(T)1g

Vinyl terminated diphenylsiloxane-dimethylsiloxane copolymer 500cSt, 100g

6,7,8,9-tetrahydro-5H-imidazo[1,5-a][1,4]diazepine dihydrochloride, 95.0%, 1g

3-(5,5-dimethyl-5,6-dihydro[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)phenol, 95.0%, 1g